Molecular Biology Kits

Molecular Biology Kits Market Outlook

The global molecular biology kits market is estimated to reach a valuation of approximately USD 24 billion by 2035, growing at a robust Compound Annual Growth Rate (CAGR) of around 10% from 2025. This significant growth can be attributed to the increasing prevalence of genetic disorders, the rising demand for personalized medicine, and advancements in research and development within the biotechnology sector. Furthermore, the growing application of molecular biology techniques in various fields, including diagnostics, forensics, and agricultural biotechnology, is expected to fuel market expansion. The rise in funding for research activities and a growing number of collaborations between academic and commercial entities also enhance the market's growth potential. As health awareness escalates and the need for rapid and efficient diagnostic tools increases, the molecular biology kits market is set to witness substantial growth in the coming years.

Growth Factor of the Market

Several key factors are driving the growth of the molecular biology kits market. Firstly, the surge in research activities related to genomics and proteomics has led to a heightened demand for molecular biology kits that can provide accurate and efficient results. Secondly, the increasing incidence of infectious diseases and genetic disorders necessitates advanced diagnostic tools, thereby driving the need for such kits in clinical diagnostics. Moreover, the expansion of biotechnology and pharmaceutical companies focusing on drug discovery and development is another significant factor that contributes to market growth. The rapid advancements in technology and the introduction of automation in laboratory processes are also pivotal in enhancing the efficiency and reliability of molecular biology kits. Furthermore, the rising adoption of personalized medicine, which relies heavily on molecular biology techniques, is expected to propel the market forward.

Key Highlights of the Market

• The molecular biology kits market is projected to grow at a CAGR of approximately 10% from 2025 to 2035.
• North America dominates the market share due to advanced research facilities and funding in biotechnology.
• DNA extraction kits hold a significant portion of the product type segment due to their widespread use in various applications.
• Clinical diagnostics represent the largest application segment, driven by the rising demand for accurate diagnostic solutions.
• The online distribution channel is witnessing a rapid growth trajectory due to the increasing preference for e-commerce platforms.

By Product Type

DNA Extraction Kits:

DNA extraction kits are the cornerstone of molecular biology, providing essential tools for isolating DNA from various sample types. The rising number of genomics projects, coupled with the demand for high-quality DNA, makes these kits crucial for researchers. Due to their reliability, efficiency, and ease of use, DNA extraction kits are frequently used in laboratories for various applications, including clinical diagnostics, forensic analysis, and genetic research. These kits are designed to yield high-purity DNA, making them a preferred choice among researchers and laboratory technicians. Additionally, advancements in extraction technologies have resulted in more streamlined processes, further propelling the demand for these kits in the molecular biology market.

RNA Purification Kits:

RNA purification kits are essential for isolating RNA from biological samples, facilitating crucial applications in gene expression studies and RNA sequencing. The increasing interest in understanding the role of RNA in cellular processes and diseases has significantly elevated the demand for these kits. Researchers utilize RNA purification kits to obtain high-quality RNA, which is vital for downstream applications, including quantitative PCR and microarray analysis. The advancement in purification techniques, such as column-based and magnetic bead methods, has improved the efficiency of these kits, making them indispensable in research laboratories. As RNA-based therapeutics and diagnostics gain traction, the market for RNA purification kits is expected to experience robust growth over the upcoming years.

PCR Kits:

Polymerase Chain Reaction (PCR) kits are pivotal in molecular biology, enabling the amplification of specific DNA sequences. These kits are widely used in various applications, including clinical diagnostics, genetic testing, and research studies. The increasing prevalence of infectious diseases and the need for rapid and accurate diagnostic methods have propelled the demand for PCR kits, particularly in the wake of global health crises. Innovations in PCR technologies, such as the development of real-time PCR and digital PCR, have further enhanced the capabilities of these kits, allowing for more precise quantification and detection of nucleic acids. As PCR techniques become increasingly essential in both research and clinical settings, the market for PCR kits continues to expand.

Cloning Kits:

Cloning kits play a crucial role in molecular biology by enabling the insertion of DNA fragments into vectors to produce recombinant DNA. These kits are extensively utilized in research applications, including gene cloning, protein expression studies, and genetic engineering. The rising emphasis on synthetic biology and genetic modifications in agriculture and pharmaceuticals has stimulated growth in the cloning kits segment. Researchers value these kits for their robustness, efficiency, and ability to streamline cloning processes. As the demand for cloned genes and proteins increases, particularly in drug development and biopharmaceuticals, the cloning kits market is poised for significant expansion.

Sequencing Kits:

Sequencing kits are integral to molecular biology, facilitating the determination of nucleic acid sequences. The rapid advancements in sequencing technologies, such as next-generation sequencing (NGS), have transformed the landscape of genomic research, leading to a surge in demand for sequencing kits. These kits allow researchers to conduct comprehensive genomic studies, including whole-genome sequencing and targeted sequencing. The growing emphasis on precision medicine and personalized healthcare, which rely heavily on genomic information, further drives the need for sequencing kits. As more applications emerge in areas like cancer research, infectious disease diagnostics, and genetic disorders, the sequencing kits market is expected to experience robust growth.

By Application

Research:

The research application segment is one of the most significant in the molecular biology kits market, driven by the increasing focus on genomics, proteomics, and molecular biology studies. Researchers employ various molecular biology kits to conduct experiments that enhance the understanding of biological processes at the molecular level. This segment benefits from substantial funding and investments in research initiatives from both public and private sectors, contributing to the continuous development of innovative molecular biology methodologies. Furthermore, collaborations between academic institutions and biotech companies have led to the development of advanced kits tailored for specific research needs, further boosting demand in this segment.

Clinical Diagnostics:

Clinical diagnostics are a dominant application segment within the molecular biology kits market, largely due to the growing need for accurate and timely diagnostic tools. With the increasing prevalence of chronic diseases and genetic disorders, molecular biology kits are vital for developing diagnostic tests that detect diseases at an early stage. These kits are instrumental in various diagnostic applications, including infectious disease testing, cancer detection, and genetic testing. The rising demand for personalized medicine is also propelling growth in this segment, as clinicians require precise molecular diagnostics to tailor treatment plans for individual patients. As advancements continue, the clinical diagnostics segment is expected to witness sustained growth.

Forensics:

The forensics application segment of the molecular biology kits market is gaining momentum as the demand for accurate and reliable forensic analysis continues to rise. Molecular biology techniques, particularly those involving DNA analysis, play a crucial role in solving criminal cases and establishing identity through genetic evidence. With the increasing focus on leveraging technology in forensic science, the adoption of molecular biology kits for DNA profiling, paternity testing, and other forensic applications is expected to grow. The integration of advanced technologies, such as automated DNA extraction and analysis systems, further enhances the efficiency and accuracy of forensic investigations, promoting market expansion.

Drug Discovery:

Drug discovery is an essential application area within the molecular biology kits market, as these kits facilitate the identification and development of new therapeutic drugs. Researchers leverage molecular biology techniques to understand the interaction between biological molecules and potential drug candidates, thereby streamlining the drug development process. The rising prevalence of chronic diseases and the push for novel therapeutics drive the demand for molecular biology kits in drug discovery. Additionally, the increasing collaboration between pharmaceutical companies and research institutions fosters innovation and the development of advanced kits tailored for specific drug discovery needs, sustaining growth in this segment.

Agriculture:

The agriculture application segment is increasingly utilizing molecular biology kits to enhance crop yield, resistance to pests, and overall agricultural productivity. Techniques such as genetic engineering and molecular markers are pivotal in developing genetically modified organisms (GMOs) and improving traditional crop varieties. The global push for sustainable agriculture practices and the need to meet growing food demands amid changing climatic conditions further boost the demand for molecular biology kits in this segment. As agricultural biotechnology advances and more countries embrace GMO crops, the agriculture application segment of the molecular biology kits market is poised for substantial growth.

By Distribution Channel

Online Stores:

Online stores have become a significant distribution channel for molecular biology kits, reflecting the broader trend of e-commerce across various industries. The convenience of purchasing products online, coupled with the vast selection available, attracts both individual researchers and large institutions. These platforms often provide detailed product information, customer reviews, and competitive pricing, which enhance the purchasing experience. Additionally, the rise of online marketplaces has facilitated quicker access to a diverse range of molecular biology kits, contributing significantly to market growth. As researchers increasingly prefer the convenience of online shopping, this channel is expected to continue its upward trajectory.

Biotech Companies:

Biotech companies play a vital role in the distribution of molecular biology kits, as they develop and manufacture innovative products catering to the needs of researchers and laboratories. These companies offer specialized kits that are often tailored to specific applications, enhancing their appeal in the market. The strong focus on R&D and the continuous introduction of new products by biotech firms significantly drive the molecular biology kits market. Furthermore, partnerships between biotech companies and academic institutions foster collaboration in developing advanced kits, further strengthening this distribution channel.

Research Institutes:

Research institutes serve as an important distribution channel for molecular biology kits, providing vital resources for academic and industrial research. Many institutes have dedicated purchasing departments that procure high-quality kits for their laboratories. The growing emphasis on research in molecular biology, genomics, and related fields leads to an increasing demand for these kits within research institutions. As funding for research initiatives expands and collaborations with industry partners grow, this distribution channel is expected to experience significant growth, driving the overall molecular biology kits market.

Hospitals & Diagnostic Centers:

Hospitals and diagnostic centers constitute a crucial distribution channel for molecular biology kits, as they utilize these tools for diagnostic testing and patient care. The rising incidence of genetic disorders, infectious diseases, and the need for precise diagnostics has led to a surge in demand for high-quality molecular biology kits in these facilities. Furthermore, the increasing adoption of molecular diagnostics in clinical settings is expected to bolster this distribution channel. As hospitals and diagnostic centers invest in advanced diagnostic technologies, the utilization of molecular biology kits will continue to expand, contributing to market growth.

Academic Institutes:

Academic institutions are significant consumers of molecular biology kits, as they play a pivotal role in training the next generation of scientists and conducting essential research. The increasing focus on hands-on learning and practical experience in academic programs drives demand for these kits, as students and researchers utilize them for various experiments. Government funding and grants often support research initiatives within academic institutions, leading to sustained investment in molecular biology kits. As educational programs in life sciences evolve and expand, the academic institutes distribution channel will remain a key driver in the molecular biology kits market.

By Sample Type

Blood:

Blood samples are one of the most commonly used sample types in molecular biology applications, particularly in clinical diagnostics and research. Molecular biology kits designed for blood samples enable the extraction and analysis of nucleic acids, facilitating various diagnostic tests and genetic studies. The increasing prevalence of blood-related diseases, such as infections and genetic disorders, drives the demand for kits that can handle blood samples efficiently. As advancements in blood analysis technologies continue, the emphasis on using molecular biology kits for blood samples is expected to grow, further propelling market expansion.

Tissue:

Tissue samples are essential in molecular biology, especially in cancer research and histopathology. Molecular biology kits tailored for tissue samples allow researchers to extract DNA, RNA, and proteins effectively, enabling comprehensive analysis. The rising incidence of cancer and the need for precise molecular characterization of tumors are significant factors driving the demand for these kits. As the focus on personalized medicine and targeted therapies increases, the importance of molecular biology kits for tissue samples will continue to grow, fostering market development.

Cells:

Cell samples are widely utilized in molecular biology applications, particularly in cell biology and genetic studies. Molecular biology kits designed for cell samples facilitate the extraction of nucleic acids and proteins, essential for various experiments. The increasing interest in cellular mechanisms and gene regulation has heightened the demand for kits that cater to cell samples. As research in cell biology expands and the focus on cell-based therapies grows, the market for molecular biology kits targeting cell samples is expected to witness significant growth.

Environmental Samples:

Environmental samples, including soil, water, and air, are gaining importance in molecular biology, particularly in ecological and environmental research. Molecular biology kits designed for environmental samples enable researchers to analyze microbial communities, detect pollutants, and study biodiversity. The rising emphasis on environmental monitoring and ecological conservation drives the demand for these kits. As regulatory bodies increasingly require environmental assessments and monitoring, the market for molecular biology kits targeting environmental samples is expected to expand substantially.

Others:

This category encompasses a diverse range of sample types, including plant samples, saliva, and other biological specimens. Molecular biology kits catering to these sample types are crucial for various applications, including agricultural research and microbiome studies. As research across multiple disciplines continues to evolve, the demand for versatile molecular biology kits that can handle various sample types will grow. The increasing focus on understanding biological processes at multiple levels drives innovation in this segment, promoting market growth.

By Region

The regional analysis of the molecular biology kits market reveals significant disparities in market dynamics and growth potential across different regions. North America is currently the dominant region, accounting for approximately 40% of the global market share. This dominance is attributed to the presence of advanced research institutions, significant funding for biotechnology, and high healthcare expenditures. The region is projected to grow at a CAGR of around 9% through 2035, fueled by continuous technological innovations and the increasing prevalence of genetic disorders. Moreover, the strong presence of leading biotech companies in North America further solidifies its market position.

Europe follows closely, holding a considerable market share, driven by strong research and development activities across various countries. The increasing emphasis on personalized medicine and the demand for efficient diagnostic tools are expected to bolster market growth in this region. The Asia Pacific region is also on an upward trajectory, with a projected CAGR of approximately 11% over the forecast period, as countries like China and India invest heavily in biotechnology research and development. The growing number of collaborations and partnerships between research institutions and biotechnology companies in Asia Pacific will further enhance the market's growth potential. Latin America and the Middle East & Africa, while smaller markets, also present opportunities for growth due to increasing investments in healthcare and research infrastructure.

Opportunities

The molecular biology kits market presents numerous opportunities for growth, particularly due to the rise of personalized medicine. As healthcare increasingly shifts towards tailored therapies, the demand for molecular diagnostics is expected to grow exponentially. Molecular biology kits are at the forefront of this transition, allowing for precise assessments of genetic makeup and disease susceptibility. Companies that develop innovative kits catering to the specific needs of personalized medicine, such as targeted gene testing kits, can capitalize on this growing trend. Moreover, the expansion of telemedicine and remote diagnostics offers a unique opportunity for the distribution of molecular biology kits, as these tools can be utilized in various settings, including patients' homes.

Additionally, the increasing emphasis on sustainable agriculture is likely to spur demand for molecular biology kits designed for agricultural applications. As the global population continues to grow, the need for higher crop yields and disease-resistant plant varieties is becoming increasingly critical. Molecular biology tools that facilitate the development of genetically modified crops or enable precise diagnostics for plant diseases will be essential. Companies that focus on creating innovative solutions for agricultural biotechnology can harness this opportunity. Furthermore, public-private partnerships aimed at promoting research and development in molecular biology can lead to new funding opportunities and collaborative projects, further driving market growth.

Threats

Despite the promising growth prospects, the molecular biology kits market faces several threats that could hinder its expansion. One major threat is the stringent regulatory environment surrounding molecular biology products, particularly in the medical and clinical diagnostics space. Regulatory agencies often impose rigorous testing and validation requirements, which can slow down the product development process and increase costs. This can deter smaller companies or startups from entering the market, limiting innovation and competition. Additionally, the rapid pace of technological advancements means that companies must continuously invest in R&D to keep up with new trends and maintain market relevance. Failure to adapt to these changes can result in obsolescence and lost market share.

Another critical threat is the increasing competition from alternative technologies and methodologies that may offer improved performance or lower costs. For instance, advancements in non-invasive diagnostic techniques could reduce the demand for traditional molecular biology kits. As competing technologies evolve, companies must consistently demonstrate the value and efficacy of their products to maintain customer loyalty. Moreover, economic factors such as recession or budget cuts in research funding can adversely impact the purchasing power of academic institutions and research organizations, leading to decreased demand for molecular biology kits. Addressing these challenges will be essential for sustained market growth.

Competitor Outlook

• Thermo Fisher Scientific
• Qiagen
• Illumina
• Agilent Technologies
• Roche
• Bio-Rad Laboratories
• NEB (New England Biolabs)
• Merck KGaA
• Promega Corporation
• Takara Bio Inc.
• Sigma-Aldrich (Merck Group)
• Biostage, Inc.
• PerkinElmer, Inc.
• Zymo Research Corp.
• Lucigen Corporation

The competitive landscape of the molecular biology kits market is characterized by a diverse array of players, ranging from established companies to emerging startups. Leading firms like Thermo Fisher Scientific and Qiagen dominate the market due to their extensive product portfolios, strong brand recognition, and significant investments in research and development. These companies continuously innovate, introducing new products and technologies to meet the evolving needs of researchers and clinicians. Furthermore, strategic partnerships and collaborations with academic institutions and research organizations enhance their competitive advantage, allowing them to stay ahead in the fast-paced biotechnology landscape.

Additionally, companies like Illumina and Agilent Technologies focus on advancing sequencing technologies and genomic research tools, catering to the growing demand for high-throughput molecular biology applications. These firms capitalize on their cutting-edge technologies and robust distribution networks to capture market share. Moreover, emerging players such as Zymo Research Corp. and Lucigen Corporation are making strides by offering specialized kits and innovative solutions that cater to niche markets. As the molecular biology field continues to evolve, companies that embrace innovation, adapt to market changes, and respond to customer needs will be well-positioned to succeed.

Furthermore, the landscape is witnessing an increasing trend of mergers and acquisitions, as companies seek to consolidate their positions and expand their product offerings. For instance, major players often acquire smaller biotechnology firms to integrate new technologies or access novel product lines. This trend enhances the competitive dynamics of the market, creating a landscape where innovation is paramount. Overall, the molecular biology kits market is poised for growth, and companies that prioritize R&D, leverage strategic partnerships, and adapt to changing market conditions will have a significant advantage in this competitive environment.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Roche
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Qiagen
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Illumina
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Merck KGaA
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Biostage, Inc.
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Takara Bio Inc.
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 PerkinElmer, Inc.
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Lucigen Corporation
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Promega Corporation
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Zymo Research Corp.
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Agilent Technologies
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Bio-Rad Laboratories
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Thermo Fisher Scientific
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 NEB (New England Biolabs)
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Sigma-Aldrich (Merck Group)
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Molecular Biology Kits Market, By Application
    • 6.1.1 Research
    • 6.1.2 Clinical Diagnostics
    • 6.1.3 Forensics
    • 6.1.4 Drug Discovery
    • 6.1.5 Agriculture
  • 6.2 Molecular Biology Kits Market, By Sample Type
    • 6.2.1 Blood
    • 6.2.2 Tissue
    • 6.2.3 Cells
    • 6.2.4 Environmental Samples
    • 6.2.5 Others
  • 6.3 Molecular Biology Kits Market, By Distribution Channel
    • 6.3.1 Online Stores
    • 6.3.2 Biotech Companies
    • 6.3.3 Research Institutes
    • 6.3.4 Hospitals & Diagnostic Centers
    • 6.3.5 Academic Institutes

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Molecular Biology Kits Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Molecular Biology Kits market is categorized based on

By Application

• Research
• Clinical Diagnostics
• Forensics
• Drug Discovery
• Agriculture

By Distribution Channel

• Online Stores
• Biotech Companies
• Research Institutes
• Hospitals & Diagnostic Centers
• Academic Institutes

By Sample Type

• Blood
• Tissue
• Cells
• Environmental Samples
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Thermo Fisher Scientific
• Qiagen
• Illumina
• Agilent Technologies
• Roche
• Bio-Rad Laboratories
• NEB (New England Biolabs)
• Merck KGaA
• Promega Corporation
• Takara Bio Inc.
• Sigma-Aldrich (Merck Group)
• Biostage, Inc.
• PerkinElmer, Inc.
• Zymo Research Corp.
• Lucigen Corporation